Feed ATEC
AT

Alphatec Holdings, Inc.

ATEC · NASDAQ

$10.18 -0.59% (-$0.06)
1M +10.17%
Market Cap $1.57B
P/E Ratio -
Div. Yield -
ROE -

Bulios Fair Price

$11.99

17.8% upside

Current Price

$10.18

Undervalued Fair Value Overvalued

According to Bulios Fair Price, ATEC is currently undervalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
5/9
Valuation
13 /100
Expensive
P/FCF 376.70x
EV/EBITDA 152.42x
P/S 1.92x
Growth
100 /100
Growing
Rev. growth 29.62%
Book val. growth N/A
EPS growth N/A
Profitability
23 /100
Weak
Op. margin 5.55%
Gross margin 66.15%
FCF margin 0.51%
Quality
18 /100
Poor
Asset turnover 1.03x
ROIC 7.55%
ROA 13.91%
Debt
20 /100
High
Net debt/EBITDA 36.07x
Current ratio 1.89x
Int. coverage -1.69x
Stability
85 /100
Stable
EPS volatility 15.87%
Beta 0.85x
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about ATEC
Online

About the company

Alphatec Holdings (ATEC) is an American company focused on the development and manufacturing of innovative medical devices and implants in the field of orthopedics and neurosurgery. Their products include a wide range of tools and implants for spine surgeries, including technologies based on artificial intelligence and 3D printing. Alphatec Holdings aims to provide comprehensive solutions for surgeons and patients, incorporating the latest technological innovations and procedures.

Sector

Healthcare

Industry

Medical - Devices

CEO

Patrick S. Miles

Employees

913

Headquarters

Carlsbad

Upcoming events

29 OCT

Earnings

Upcoming earnings report

38d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.